Aragon Pharmaceuticals' Series B Round

Aragon Pharmaceuticals raised a round of funding on April 22, 2010.

Aragon Pharmaceuticals is a small-molecule drug discovery company focused on developing medicines for the treatment of hormonally-driven cancers. These cancers eventually become resistant to existing …

Articles about Aragon Pharmaceuticals' Series B Round: